Authors:
Calisher, CH
Blair, CD
Bowen, MD
Casals, J
Drebot, MA
Henchal, EA
Karabatsos, N
LeDuc, JW
Repik, PM
Roehrig, JT
Schmaljohn, CS
Shope, RE
Tesh, RB
Weaver, SC
Citation: Ch. Calisher et al., Identification of arboviruses and certain rodent-borne viruses: Reevaluation of the paradigm, EM INFECT D, 7(4), 2001, pp. 756-758
Authors:
Saeed, MF
Nunes, M
Vasconcelos, PF
Da Rosa, APAT
Watts, DM
Russell, K
Shope, RE
Tesh, RB
Barrett, ADT
Citation: Mf. Saeed et al., Diagnosis of oropouche virus infection using a recombinant nucleocapsid protein-based enzyme immunoassay, J CLIN MICR, 39(7), 2001, pp. 2445-2452
Authors:
Holbrook, MR
Ni, H
Shope, RE
Barrett, ADT
Citation: Mr. Holbrook et al., Amino acid substitution(s) in the stem-anchor region of Langat virus envelope protein attenuates mouse neurovirulence, VIROLOGY, 286(1), 2001, pp. 54-61
Authors:
Bhardwaj, S
Holbrook, M
Shope, RE
Barrett, ADT
Watowich, SJ
Citation: S. Bhardwaj et al., Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein, J VIROLOGY, 75(8), 2001, pp. 4002-4007
Authors:
Wang, EY
Bowen, RA
Medina, G
Powers, AM
Kang, WL
Chandler, LM
Shope, RE
Weaver, SC
Citation: Ey. Wang et al., Virulence and viremia characteristics of 1992 epizootic subtype IC Venezuelan equine encephalitis viruses and closely related enzootic subtype ID strains, AM J TROP M, 65(1), 2001, pp. 64-69
Authors:
Kanesa-thasan, N
Smucny, JJ
Hoke, CH
Marks, DH
Konishi, E
Kurane, I
Tang, DB
Vaughn, DW
Mason, PW
Shope, RE
Citation: N. Kanesa-thasan et al., Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus - poxvirus vaccines in vaccinia-nonimmune andvaccinia-immune humans, VACCINE, 19(4-5), 2000, pp. 483-491
Authors:
Konishi, E
Kurane, I
Mason, PW
Shope, RE
Kanesa-Thasan, N
Smucny, JJ
Hope, CH
Ennis, FA
Citation: E. Konishi et al., Introduction of Japanese encephalitis virus-specific cytotoxic T-lymphocytes in humans by poxvirus-based JE vaccine candidates (vol 16, pg 842, 1998, VACCINE, 17(5), 1999, pp. I-I
Authors:
Sohn, YM
Park, MS
Rho, HO
Chandler, LJ
Shope, RE
Tsai, TF
Citation: Ym. Sohn et al., Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants, VACCINE, 17(18), 1999, pp. 2259-2264
Authors:
Monath, TP
Soike, K
Levenbook, I
Zhang, ZX
Arroyo, J
Delagrave, S
Myers, G
Barrett, ADT
Shope, RE
Ratterree, M
Chambers, TJ
Guirakhoo, F
Citation: Tp. Monath et al., Recombinant, chimaeric live, attenuated vaccine (ChimeriVax (TM)) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and thecapsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in nonhuman primates, VACCINE, 17(15-16), 1999, pp. 1869-1882
Authors:
Brault, AC
Powers, AM
Chavez, CLV
Lopez, RN
Cachon, MF
Gutierrez, LFL
Kang, WL
Tesh, RB
Shope, RE
Weaver, SC
Citation: Ac. Brault et al., Genetic and antigenic diversity among eastern equine encephalitis viruses from North, Central, and South America, AM J TROP M, 61(4), 1999, pp. 579-586
Authors:
Defraites, RF
Gambel, JM
Hoke, CH
Sanchez, JL
Withers, BG
Karabatsos, N
Shope, RE
Tirrell, S
Yoshida, I
Takagi, M
Meschievitz, CK
Tsai, TF
Citation: Rf. Defraites et al., Japanese encephalitis vaccine (inactivated, BIKEN) in US soldiers: Immunogenicity and safety of vaccine administered in two dosing regimens, AM J TROP M, 61(2), 1999, pp. 288-293
Citation: Ll. Walters et al., Seroepidemiology of California and Bunyamwera serogroup (Bunyaviridae) virus infections in native populations of Alaska, AM J TROP M, 60(5), 1999, pp. 806-821